ImmuPharma plc (LON:IMM – Get Free Report) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1.95 ($0.03) and traded as low as GBX 1.54 ($0.02). ImmuPharma shares last traded at GBX 1.56 ($0.02), with a volume of 272,764 shares traded.
ImmuPharma Stock Up 2.3 %
The firm has a market cap of £6.48 million, a price-to-earnings ratio of -155.50 and a beta of 1.53. The company’s 50-day moving average price is GBX 1.70 and its 200-day moving average price is GBX 1.96.
ImmuPharma Company Profile
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
Further Reading
- Five stocks we like better than ImmuPharma
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- Comparing and Trading High PE Ratio Stocks
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
